Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15508765 | 0.81 | USP2 (0.35) | USP2TSHRMAPTHPGD | |
| SCHEMBL11765145 | 0.80 | SLC22A6 (0.37) | SLC22A6HPGD | |
| SCHEMBL12363181 | 0.79 | HPGD (0.38) | MAPTHPGD | |
| SCHEMBL29066133 | 0.79 | HSD17B10 (0.48) | USP2SLC22A6MAPT | |
| SCHEMBL28914089 | 0.78 | SLC22A6 (0.36) | USP2TSHRSLC22A6 | |
| SCHEMBL9813953 | 0.77 | TSHR (0.37) | USP2TSHRSLC22A6HPGD | |
| SCHEMBL15274086 | 0.77 | HPGD (0.51) | TSHRSLC22A6HPGD | |
| SCHEMBL31147863 | 0.76 | CA1 (0.34) | SLC22A6 | |
| Sulfuric Acid SCHEMBL29055240 | 0.76 | USP2 (0.41) | USP2TSHRMAPT | |
| SCHEMBL15478589 | 0.76 | SLC22A6 (0.34) | SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8986726-B2 | Biocompatible polyacrylate compositions for medical applications | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-03-24 | — | — | US | claimed |
| US-8871236-B2 | Biocompatible polyacrylate compositions for medical applications | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-10-28 | — | — | US | claimed |
| US-8647655-B2 | Biocompatible polyacrylate compositions for medical applications | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-02-11 | — | — | US | claimed |
| US-20130273234-A1 | Biocompatible Polyacrylate Compositions For Medical Applications | ABBOTT CARDIOVASCULAR SYSTEMS, INC. (US) | 2013-10-17 | — | — | US | claimed |
| US-20130266619-A1 | Biocompatible Polyacrylate Compositions For Medical Applications | ADVANCED CARDIOVASCULAR SYSTEM (US) | 2013-10-10 | — | — | US | claimed |
| US-20100255058-A1 | BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2010-10-07 | — | — | US | claimed |
| US-7776926-B1 | Blend of a biologically compatible structural component such as an acrylic ester (co)polymer, and a copolymer having a biobeneficial or bioactive moiety, such as a block copolymer of polyethylene glycol and a polyacrylate; coating medical devices such as stents | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2010-08-17 | — | — | US | claimed |
| EP-1748806-A1 | BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-02-07 | — | — | EP | claimed |
| WO-2005097227-A1 | BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2005-10-20 | — | — | WO | claimed |
| US-20050169957-A1 | Blend of a biologically compatible structural component such as an acrylic ester (co)polymer, and a copolymer having a biobeneficial or bioactive moiety, such as a block copolymer of polyethylene glycol and a polyacrylate; coating medical devices such as stents | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2005-08-04 | — | — | US | claimed |
| US-20170334840-A1 | LARGE HYDROPHOBE SURFACTANTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2017-11-23 | — | — | US | disclosed |
| US-20170166802-A1 | PHENOL-ALKOXYLATE CO-SOLVENT SURFACTANT COMPOSITION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS | 2017-06-15 | — | — | US | disclosed |
| US-20170044423-A1 | GEMINI EPOXIDE SURFACTANT COMPOSITIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-02-16 | — | — | US | disclosed |
| US-20160069168-A1 | Novel large hydrophobe quaternary ammonium surfactants | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2016-03-10 | — | — | US | disclosed |
| US-20150267870-A1 | USE OF AMINES IN HEAVY OIL TRANSPORT | UNIV TEXAS (US) | 2015-09-24 | — | — | US | disclosed |
| US-4239801-A | POLYESTER CONTAINING N,N-BIS(HYDROXYALKYL) TAURINE SALT UNITS | BASF WYANDOTTE CORPORATION (US) | 1980-12-16 | — | — | US | disclosed |
| US-4215026-A | Aqueous dispersion of a branched polyester | BASF WYANDOTTE CORP. (US) | 1980-07-29 | — | — | US | disclosed |
| US-4158083-A | Fibrous article sized with a branched water-dispersible polyester | BASF WYANDOTTE CORPORATION (US) | 1979-06-12 | — | — | US | disclosed |
| US-4156073-A | Branched water-dispersible polyester | BASF WYANDOTTE CORPORATION (US) | 1979-05-22 | — | — | US | disclosed |
| US-4080315-A | Polyesters of N,N-bis(hydroxyalkyl) taurine salts as antistatic agents for synthetic polymers | BASF WYANDOTTE CORPORATION (US) | 1978-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334840-A1 | LARGE HYDROPHOBE SURFACTANTS | ERG28, LIPA, SMURF1 | USP2 875/4885TSHR 4335/4885SLC22A6 3137/4885 |
| US-20100255058-A1 | BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS FOR MEDICAL APPLICATIONS | CD68, CAD, ILK | USP2 1565/4885TSHR 4845/4885SLC22A6 2438/4885 |
| US-20170044423-A1 | GEMINI EPOXIDE SURFACTANT COMPOSITIONS | SGMS2, SGMS1, GEMIN4 | USP2 2192/4885TSHR 4623/4885SLC22A6 4327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.